Home / SFOSF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does SFOSF make money? Does SFOSF have pricing power? What's the Earnings Whisper? Will SFOSF profit more as the business scales? What is SFOSF's management track record? Is SFOSF's current price justified?

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

$1.93 -$0.85 (-30.50%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$2.2

Day Range

$1.93$2.2

Year Range

$1.93$3.5

Market Cap

5.11B

AVG Volume

225

Trailing/Forward PE

17.13/1.14

PEG ratio

1.44

Dividend Yield

1.78%

Next Earnings Date

2027-03-29

Primary Exchange

Other OTC

Revenue (CNY)

SFOSF Revenue (CNY) by year
Period	Revenue (CNY)
2025	51.1B
2024	40.9B
2023	41.33B
2022	43.95B
2021	39.01B
2020	30.31B
2019	28.59B
2018	24.92B
2017	18.53B
2016	14.63B

Net Income (CNY)

SFOSF Net Income (CNY) by year
Period	Net Income (CNY)
2025	4.16B
2024	2.77B
2023	2.39B
2022	3.91B
2021	4.74B
2020	3.66B
2019	3.32B
2018	2.71B
2017	3.12B
2016	2.81B

Operating Income (CNY)

SFOSF Operating Income (CNY) by year
Period	Operating Income (CNY)
2025	5.26B
2024	3.9B
2023	3.29B
2022	6.62B
2021	6.31B
2020	4.72B
2019	4.49B
2018	3.54B
2017	4.07B
2016	3.4B

EBITDA (CNY)

SFOSF EBITDA (CNY) by year
Period	EBITDA (CNY)
2025	8.35B
2024	6.59B
2023	7.23B
2022	7.25B
2021	7.5B
2020	5.83B
2019	6.32B
2018	4.82B
2017	6.1B
2016	5.23B

Cash Flows (CNY)

SFOSF Cash Flows (CNY) by year
Period	Cash Flows (CNY)
2025	764.78M
2024	302.51M
2023	-1.75B
2022	-1.75B
2021	-1.02B
2020	-1.86B
2019	-739.65M
2018	-224.81M
2017	409.61M
2016	188.08M

EPS (CNY)

SFOSF EPS (CNY) by year
Period	EPS (CNY)
2025	1.57
2024	1.05
2023	0.9
2022	1.5
2021	1.8
2020	1.44
2019	1.33
2018	1.05
2017	1.29
2016	1.2

Expenses (CNY)

SFOSF Expenses (CNY) by year
Period	Expenses (CNY)
2025	16.24B
2024	17.41B
2023	23.4B
2022	20.35B
2021	18.75B
2020	15.71B
2019	15.93B
2018	13.13B
2017	9.69B
2016	6.51B

Cash & Debt (CNY)

SFOSF Cash & Debt (CNY) by year
Period	Cash & Debt (CNY)
2025	15.78B
2024	16.12B
2023	15.58B
2022	17.17B
2021	14.55B
2020	11.93B
2019	9.99B
2018	9.16B
2017	7.47B
2016	6.04B

Debt ratios

SFOSF Debt ratios by year
Period	Debt ratios
2025	0.71
2024	0.55
2023	0.72
2022	0.49
2021	0.4
2020	0.52
2019	0.53
2018	0.66

Margins

SFOSF Margins by year
Period	Margins
2025	49.7%
2024	46.91%
2023	46.72%
2022	47.28%
2021	48.14%
2020	55.68%
2019	59.62%
2018	58.4%
2017	58.94%
2016	54.07%

Return on Capital

SFOSF Return on Capital by year
Period	Return on Capital
2025	6.73%
2024	4.62%
2023	4.21%
2022	7.23%
2021	9.79%
2020	7.97%
2019	8.47%
2018	8.06%
2017	10.51%
2016	11.11%

Shares Outstanding

SFOSF Shares Outstanding by year
Period	Shares Outstanding
2025	2.64B
2024	2.66B
2023	2.67B
2022	2.67B
2021	2.53B
2020	2.55B
2019	2.49B
2018	2.55B
2017	2.51B
2016	2.33B

Dividends (CNY)

SFOSF Dividends (CNY) by year
Period	Dividends (CNY)
2026	0.06
2025	0.04
2024	0.04
2023	0.06
2022	0.08
2021	0.07
2020	0.43
2019	0.36
2018	0.46
2017	0.05

Book Value Per Share (CNY)

SFOSF Book Value Per Share (CNY) by year
Period	Book Value Per Share (CNY)
2025	23.43
2024	22.5
2023	21.2
2022	20.27
2021	19.12
2020	18.05
2019	15.75
2018	13.15
2017	11.85
2016	10.85

Total Assets (CNY)

SFOSF Total Assets (CNY) by year
Period	Total Assets (CNY)
2025	120.08B
2024	117.46B
2023	114.03B
2022	107.16B
2021	93.29B
2020	83.69B
2019	76.12B
2018	70.55B
2017	61.97B
2016	43.77B

PE Ratio

SFOSF PE Ratio by year
Period	PE Ratio
Sep 26	8
Sep 26	9.12
Aug 26	9.14
Aug 26	9.14
Aug 26	8.12
Aug 26	9.17
Jul 26	9.18
Jul 26	9.21
Jul 26	9.21
Jul 26	9.21
Jul 26	8.47
Jun 26	8.7
Jun 26	8.67
Jun 26	8.66
Jun 26	9.3
May 26	9.31
May 26	9.34
May 26	10.44
May 26	11.21
May 26	11.25
Apr 26	11.26
Apr 26	11.67
Apr 26	11.68
Apr 26	11.78
Mar 26	15.06
Mar 26	13.51
Mar 26	13.58
Mar 26	12.97
Feb 26	14.45
Feb 26	14.55
Feb 26	14.55
Feb 26	14.62
Jan 26	16.05
Jan 26	16.07
Jan 26	15.64
Jan 26	15.66
Jan 26	15.69
Dec 25	15.92
Dec 25	16
Dec 25	19.09
Dec 25	19.14
Nov 25	19.15
Nov 25	19.23
Nov 25	19.21
Nov 25	19.28
Oct 25	19.26
Oct 25	19.27
Oct 25	19.29
Oct 25	19.31
Oct 25	19.33
Sep 25	22.73
Sep 25	20.41
Sep 25	20.43
Sep 25	18.51
Aug 25	14.93
Aug 25	15
Aug 25	15.04
Aug 25	15.04
Aug 25	17.53
Jul 25	12.79
Jul 25	12.81
Jul 25	12.79
Jul 25	12.79
Jun 25	13.52
Jun 25	13.49
Jun 25	13.53
Jun 25	13.55
May 25	13.64
May 25	13.6
May 25	13.52
May 25	13.57
May 25	13.63
Apr 25	13.66
Apr 25	13.68
Apr 25	13.67
Apr 25	13.65
Mar 25	17.84
Mar 25	17.35
Mar 25	17.32
Mar 25	18.31
Feb 25	18.44
Feb 25	18.26
Feb 25	17.18
Feb 25	16.52
Jan 25	15.53
Jan 25	15.51
Jan 25	15.68
Jan 25	15.7
Jan 25	15.67
Dec 24	18.92
Dec 24	18.91
Dec 24	18.86
Dec 24	18.85
Nov 24	21.09
Nov 24	21.1
Nov 24	21.06
Nov 24	22.37
Nov 24	18.98
Oct 24	18.97
Oct 24	18.93

Free Cash Flow Yield

SFOSF Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	2.59%
Sep 26	2.27%
Aug 26	2.27%
Aug 26	2.27%
Aug 26	2.55%
Aug 26	2.26%
Jul 26	2.26%
Jul 26	2.25%
Jul 26	2.25%
Jul 26	2.25%
Jul 26	2.45%
Jun 26	2.11%
Jun 26	2.12%
Jun 26	2.12%
Jun 26	1.97%
May 26	1.97%
May 26	1.97%
May 26	1.76%
May 26	1.64%
May 26	1.63%
Apr 26	1.63%
Apr 26	1.57%
Apr 26	1.57%
Apr 26	1.56%
Mar 26	0.65%
Mar 26	0.72%
Mar 26	0.72%
Mar 26	0.75%
Feb 26	0.68%
Feb 26	0.67%
Feb 26	0.67%
Feb 26	0.67%
Jan 26	0.61%
Jan 26	0.61%
Jan 26	0.62%
Jan 26	0.62%
Jan 26	0.62%
Dec 25	0.61%
Dec 25	0.6%
Dec 25	0.51%
Dec 25	0.5%
Nov 25	0.5%
Nov 25	0.5%
Nov 25	0.5%
Nov 25	0.5%
Oct 25	0.5%
Oct 25	0.5%
Oct 25	0.5%
Oct 25	0.5%
Oct 25	0.5%
Sep 25	0.66%
Sep 25	0.73%
Sep 25	0.73%
Sep 25	0.81%
Aug 25	1%
Aug 25	1%
Aug 25	1%
Aug 25	1%
Aug 25	0.85%
Jul 25	1.17%
Jul 25	1.17%
Jul 25	1.17%
Jul 25	1.17%
Jun 25	0.81%
Jun 25	0.81%
Jun 25	0.81%
Jun 25	0.81%
May 25	0.8%
May 25	0.8%
May 25	0.81%
May 25	0.8%
May 25	0.8%
Apr 25	0.8%
Apr 25	0.8%
Apr 25	0.8%
Apr 25	0.8%
Mar 25	0.24%
Mar 25	0.24%
Mar 25	0.24%
Mar 25	0.23%
Feb 25	0.23%
Feb 25	0.23%
Feb 25	0.25%
Feb 25	0.26%
Jan 25	0.27%
Jan 25	0.27%
Jan 25	0.27%
Jan 25	0.27%
Jan 25	0.27%
Dec 24	-1.96%
Dec 24	-1.96%
Dec 24	-1.97%
Dec 24	-1.97%
Nov 24	-1.76%
Nov 24	-1.76%
Nov 24	-1.76%
Nov 24	-1.66%
Nov 24	-1.95%
Oct 24	-1.95%
Oct 24	-1.96%

Price to Sales

SFOSF Price to Sales by year
Period	Price to Sales
Sep 26	0.66
Sep 26	0.75
Aug 26	0.75
Aug 26	0.75
Aug 26	0.67
Aug 26	0.76
Jul 26	0.76
Jul 26	0.76
Jul 26	0.76
Jul 26	0.76
Jul 26	0.7
Jun 26	0.71
Jun 26	0.71
Jun 26	0.71
Jun 26	0.76
May 26	0.76
May 26	0.76
May 26	0.85
May 26	0.91
May 26	0.92
Apr 26	0.92
Apr 26	0.95
Apr 26	0.95
Apr 26	0.96
Mar 26	1.25
Mar 26	1.12
Mar 26	1.13
Mar 26	1.08
Feb 26	1.2
Feb 26	1.21
Feb 26	1.21
Feb 26	1.21
Jan 26	1.33
Jan 26	1.33
Jan 26	1.3
Jan 26	1.3
Jan 26	1.3
Dec 25	1.29
Dec 25	1.29
Dec 25	1.55
Dec 25	1.55
Nov 25	1.55
Nov 25	1.56
Nov 25	1.56
Nov 25	1.56
Oct 25	1.56
Oct 25	1.56
Oct 25	1.56
Oct 25	1.56
Oct 25	1.56
Sep 25	1.65
Sep 25	1.48
Sep 25	1.48
Sep 25	1.34
Aug 25	1.08
Aug 25	1.09
Aug 25	1.09
Aug 25	1.09
Aug 25	1.27
Jul 25	0.93
Jul 25	0.93
Jul 25	0.93
Jul 25	0.93
Jun 25	0.92
Jun 25	0.91
Jun 25	0.92
Jun 25	0.92
May 25	0.92
May 25	0.92
May 25	0.92
May 25	0.92
May 25	0.92
Apr 25	0.93
Apr 25	0.93
Apr 25	0.93
Apr 25	0.92
Mar 25	0.91
Mar 25	0.89
Mar 25	0.88
Mar 25	0.94
Feb 25	0.94
Feb 25	0.93
Feb 25	0.88
Feb 25	0.84
Jan 25	0.79
Jan 25	0.79
Jan 25	0.8
Jan 25	0.8
Jan 25	0.8
Dec 24	0.86
Dec 24	0.86
Dec 24	0.86
Dec 24	0.86
Nov 24	0.96
Nov 24	0.96
Nov 24	0.96
Nov 24	1.02
Nov 24	0.87
Oct 24	0.86
Oct 24	0.86

EV/EBITDA

SFOSF EV/EBITDA by year
Period	EV/EBITDA
Sep 26	6.14
Sep 26	6.72
Aug 26	6.73
Aug 26	6.73
Aug 26	6.2
Aug 26	6.74
Jul 26	6.75
Jul 26	6.76
Jul 26	6.76
Jul 26	6.76
Jul 26	6.38
Jun 26	6.84
Jun 26	6.82
Jun 26	6.81
Jun 26	7.14
May 26	7.14
May 26	7.16
May 26	7.71
May 26	8.08
May 26	8.11
Apr 26	8.11
Apr 26	8.31
Apr 26	8.32
Apr 26	8.37
Mar 26	11.57
Mar 26	10.77
Mar 26	10.81
Mar 26	10.5
Feb 26	11.25
Feb 26	11.31
Feb 26	11.31
Feb 26	11.34
Jan 26	12.07
Jan 26	12.08
Jan 26	11.86
Jan 26	11.87
Jan 26	11.89
Dec 25	9.92
Dec 25	9.95
Dec 25	11.42
Dec 25	11.43
Nov 25	11.44
Nov 25	11.48
Nov 25	11.47
Nov 25	11.5
Oct 25	11.49
Oct 25	11.5
Oct 25	11.51
Oct 25	11.52
Oct 25	11.52
Sep 25	12.73
Sep 25	11.68
Sep 25	11.7
Sep 25	10.83
Aug 25	9.21
Aug 25	9.24
Aug 25	9.26
Aug 25	9.26
Aug 25	10.39
Jul 25	8.25
Jul 25	8.25
Jul 25	8.25
Jul 25	8.25
Jun 25	8.04
Jun 25	8.03
Jun 25	8.05
Jun 25	8.05
May 25	8.09
May 25	8.08
May 25	8.04
May 25	8.06
May 25	8.09
Apr 25	8.1
Apr 25	8.11
Apr 25	8.11
Apr 25	8.1
Mar 25	8.26
Mar 25	8.09
Mar 25	8.09
Mar 25	8.42
Feb 25	8.46
Feb 25	8.4
Feb 25	8.04
Feb 25	7.82
Jan 25	7.48
Jan 25	7.48
Jan 25	7.53
Jan 25	7.54
Jan 25	7.53
Dec 24	9.37
Dec 24	9.37
Dec 24	9.36
Dec 24	9.35
Nov 24	10.07
Nov 24	10.07
Nov 24	10.06
Nov 24	10.47
Nov 24	9.39
Oct 24	9.39
Oct 24	9.38

Price/Operating Cashflow

SFOSF Price/Operating Cashflow by year
Period	Price/Operating Cashflow
Sep 26	6.44
Sep 26	7.34
Aug 26	7.36
Aug 26	7.35
Aug 26	6.54
Aug 26	7.38
Jul 26	7.39
Jul 26	7.41
Jul 26	7.41
Jul 26	7.41
Jul 26	6.82
Jun 26	6.95
Jun 26	6.92
Jun 26	6.92
Jun 26	7.43
May 26	7.43
May 26	7.46
May 26	8.34
May 26	8.95
May 26	8.99
Apr 26	9
Apr 26	9.32
Apr 26	9.33
Apr 26	9.41
Mar 26	10.15
Mar 26	9.1
Mar 26	9.15
Mar 26	8.74
Feb 26	9.73
Feb 26	9.8
Feb 26	9.8
Feb 26	9.85
Jan 26	10.81
Jan 26	10.83
Jan 26	10.53
Jan 26	10.55
Jan 26	10.57
Dec 25	9.42
Dec 25	9.47
Dec 25	11.3
Dec 25	11.32
Nov 25	11.33
Nov 25	11.38
Nov 25	11.37
Nov 25	11.41
Oct 25	11.4
Oct 25	11.4
Oct 25	11.41
Oct 25	11.43
Oct 25	11.44
Sep 25	12.1
Sep 25	10.86
Sep 25	10.87
Sep 25	9.85
Aug 25	7.95
Aug 25	7.99
Aug 25	8
Aug 25	8.01
Aug 25	9.33
Jul 25	6.81
Jul 25	6.82
Jul 25	6.81
Jul 25	6.81
Jun 25	6.81
Jun 25	6.8
Jun 25	6.82
Jun 25	6.83
May 25	6.87
May 25	6.85
May 25	6.81
May 25	6.84
May 25	6.87
Apr 25	6.88
Apr 25	6.9
Apr 25	6.89
Apr 25	6.88
Mar 25	7.51
Mar 25	7.31
Mar 25	7.29
Mar 25	7.71
Feb 25	7.77
Feb 25	7.69
Feb 25	7.23
Feb 25	6.96
Jan 25	6.54
Jan 25	6.53
Jan 25	6.61
Jan 25	6.61
Jan 25	6.6
Dec 24	9.11
Dec 24	9.11
Dec 24	9.08
Dec 24	9.08
Nov 24	10.16
Nov 24	10.16
Nov 24	10.14
Nov 24	10.77
Nov 24	9.14
Oct 24	9.14
Oct 24	9.11

Price to Book

SFOSF Price to Book by year
Period	Price to Book
Sep 26	0.54
Sep 26	0.61
Aug 26	0.61
Aug 26	0.61
Aug 26	0.54
Aug 26	0.62
Jul 26	0.62
Jul 26	0.62
Jul 26	0.62
Jul 26	0.62
Jul 26	0.57
Jun 26	0.59
Jun 26	0.58
Jun 26	0.58
Jun 26	0.63
May 26	0.63
May 26	0.63
May 26	0.7
May 26	0.75
May 26	0.76
Apr 26	0.76
Apr 26	0.79
Apr 26	0.79
Apr 26	0.79
Mar 26	0.81
Mar 26	0.73
Mar 26	0.73
Mar 26	0.7
Feb 26	0.78
Feb 26	0.79
Feb 26	0.79
Feb 26	0.79
Jan 26	0.87
Jan 26	0.87
Jan 26	0.84
Jan 26	0.85
Jan 26	0.85
Dec 25	0.86
Dec 25	0.86
Dec 25	1.03
Dec 25	1.03
Nov 25	1.03
Nov 25	1.04
Nov 25	1.03
Nov 25	1.04
Oct 25	1.04
Oct 25	1.04
Oct 25	1.04
Oct 25	1.04
Oct 25	1.04
Sep 25	1.09
Sep 25	0.98
Sep 25	0.98
Sep 25	0.89
Aug 25	0.72
Aug 25	0.72
Aug 25	0.72
Aug 25	0.72
Aug 25	0.84
Jul 25	0.61
Jul 25	0.62
Jul 25	0.61
Jul 25	0.61
Jun 25	0.62
Jun 25	0.62
Jun 25	0.63
Jun 25	0.63
May 25	0.63
May 25	0.63
May 25	0.62
May 25	0.63
May 25	0.63
Apr 25	0.63
Apr 25	0.63
Apr 25	0.63
Apr 25	0.63
Mar 25	0.64
Mar 25	0.62
Mar 25	0.62
Mar 25	0.65
Feb 25	0.66
Feb 25	0.65
Feb 25	0.61
Feb 25	0.59
Jan 25	0.55
Jan 25	0.55
Jan 25	0.56
Jan 25	0.56
Jan 25	0.56
Dec 24	0.59
Dec 24	0.59
Dec 24	0.59
Dec 24	0.59
Nov 24	0.66
Nov 24	0.66
Nov 24	0.66
Nov 24	0.7
Nov 24	0.59
Oct 24	0.59
Oct 24	0.59

No video analysis for this stock yet. Request one from our team.

News: SFOSF

prnewswire.com · 6 Sep 2026

Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 Billion

SHANGHAI, Sept. 6, 2026 /PRNewswire/ -- Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma", stock code: 600196.SH; 02196.HK) today announced an H-share repurchase plan, under which the company intends to repurchase its H-shares with an aggregate amount of up to HK$1 billion. The shares so repurchased will be cancelled or held as treasury shares. Taking concrete action to respond to market concerns, this repurchase plan demonstrates management's unwavering confidence in the company's intrinsic value. The plan has come into effect and will be implemented as soon as practicable. As a continuation of the Group's long-term value management toolkit, the company will dynamically evaluate and execute repurchases on a rolling basis in response to market conditions, establishing a normalized mechanism for shareholder returns.

AI Analysis

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Video analysis: SFOSF

News: SFOSF

Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 Billion

Similar companies